Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

TCRX

Tscan Therapeutics Inc

May 05 • 04:00PM ET

1.21

-0.01 -0.82 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: GILD CRSP ALLO NTLA FATE BLUE EDIT CLLS PGEN ADAP

| Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.00	Insider Own	15.89%	Shs Outstand	52.63M	Perf Week	-3.97%
Market Cap	72.72M	Forward P/E	-	EPS next Y	-0.87	Insider Trans	1.72%	Shs Float	50.55M	Perf Month	16.35%
Enterprise Value	14.45M	PEG	-	EPS next Q	-0.20	Inst Own	47.65%	Short Float	1.87%	Perf Quarter	21.51%
Income	-129.77M	P/S	7.05	EPS this Y	6.87%	Inst Trans	-8.35%	Short Ratio	1.15	Perf Half Y	-37.63%
Sales	10.32M	P/B	0.56	EPS next Y	6.84%	ROA	-43.26%	Short Interest	0.94M	Perf YTD	21.00%
Book/sh	2.16	P/C	0.48	EPS next 5Y	6.88%	ROE	-71.28%	52W High	2.57 -52.92%	Perf Year	-19.33%
Cash/sh	2.54	P/FCF	-	EPS past 3/5Y	28.66% 2.08%	ROIC	-61.77%	52W Low	0.88 37.13%	Perf 3Y	-49.58%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-8.63% 56.92%	Gross Margin	72.25%	Volatility	7.97% 8.72%	Perf 5Y	-
Dividend TTM	-	EV/Sales	1.40	EPS Y/Y TTM	12.67%	Oper. Margin	-1315.38%	ATR (14)	0.10	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	8.41	Sales Y/Y TTM	266.65%	Profit Margin	-1256.81%	RSI (14)	53.89	Recom	1.33
Dividend Gr. 3/5Y	- -	Current Ratio	8.41	EPS Q/Q	40.34%	SMA20	2.85%	Beta	1.06	Target Price	6.00
Payout	-	Debt/Eq	0.76	Sales Q/Q	286.02%	SMA50	8.90%	Rel Volume	1.21	Prev Close	1.22
Employees	142	LT Debt/Eq	0.71	Earnings	Mar 04 BMO	SMA200	-12.50%	Avg Volume	823.44K	Price	1.21
IPO	Jul 16, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	33.41% 5.40%	Trades		Volume	1,000,765	Change	-0.82%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)